chrisvoncsefalvay/vaers-outcomes huggingface dataset:
receives one dose of Shingrix but it has now been over a year and they never received the second dose; This non-serious case was reported by a physician via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: receives one dose of Shingrix but it has now been over a year and they never received the second dose).The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 20-SEP-2023 The reporter wanted to know if a patient received one dose of Shingrix but it had now been over a year and they never received the second dose, could we give it or we had to start all over with the series. Till the time of reporting , the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.
Received vaccine Sat sore arm that night and 24 hours later felt very tired, felt warm and body aches, was unable to get up for work Monday morning and had cough.
Information has been received from a physician concerning a female who was vaccinated with her second dose of GARDASIL.  Concomitant therapy included influenza virus vaccine (unspecified).  Subsequently the patient fainted after receiving both vaccines.  The patient sought unspecified medical attention.  Additional information has been requested.
sharp pain in his neck; pain in his armpit; sore; pain in both hips; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (sharp pain in his neck), MYALGIA (sore), ARTHRALGIA (pain in both hips) and MYALGIA (pain in his armpit) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced MYALGIA (sore) and ARTHRALGIA (pain in both hips). On 12-Mar-2021, the patient experienced MYALGIA (pain in his armpit). On 15-Mar-2021, the patient experienced NECK PAIN (sharp pain in his neck). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 13-Mar-2021, MYALGIA (pain in his armpit) had resolved. At the time of the report, NECK PAIN (sharp pain in his neck), MYALGIA (sore) and ARTHRALGIA (pain in both hips) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported No treatment drugs were reported
I got the vax and they monitored me for 30 min and I was fine, returned home and I fell asleep. When I woke up I had hives on my throat, chest and face. I called my allergist Dr. to see if she told me to take all my allergy medications and she told me to take the monolukast the night before and take claritin and zyrtec for 2nd dose.  I took a full dose of hydroxizine and it worked. After a couple of hours the hives were gone.
The pt experienced a red area with knot at injection site. Treated with Benadryl and cool compresses to the area, Tylenol for pain and fever. Instructed to call back if area worsens.
Shortness of breath shortly after vaccination.  Found to have extensive pulmonary embolism on CTPE a week after vaccination. Patient has no other risk factors. Started on heparin drip on admission. Discharged with DOAC. Will follow up with hematology and oncology outpatient for hypercoagulable workup
In the evening of the day after the vaccinations, I noticed patient having a slight stutter. She would repeat the first syllable in a word, usually the first word in her sentence, multiple times. She seemed very strained. She also started acting more agitated, irritable, unpredictable with some of her social behaviors. The stutter got progressively worse. Sometimes the stutter of just one letter would last five of six seconds, and by the new year (1/2011) I was seeing more than one stutter in a sentence sometimes. But it was not consistant. Since then, the stutter and the behavioral problems have been slightly improving.
diarrhea; dizziness; shortness of breath; vomiting; headache; muscle aches; body aches; nausea; 102.5 degree fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), DIZZINESS (dizziness), DYSPNOEA (shortness of breath), VOMITING (vomiting) and HEADACHE (headache) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011a21a and 012m20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS (DAILY VITAMINS) for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea), DIZZINESS (dizziness), DYSPNOEA (shortness of breath), VOMITING (vomiting), HEADACHE (headache), MYALGIA (muscle aches), MYALGIA (body aches), NAUSEA (nausea) and PYREXIA (102.5 degree fever). At the time of the report, DIARRHOEA (diarrhea), DIZZINESS (dizziness), DYSPNOEA (shortness of breath), VOMITING (vomiting), HEADACHE (headache), MYALGIA (muscle aches), MYALGIA (body aches), NAUSEA (nausea) and PYREXIA (102.5 degree fever) outcome was unknown.            Treatment medication was not provided. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD21-088796 (E2B Linked Report).; Sender's Comments:  MOD21-088796:Husband's case
Headache; FATIGUE; CHILLS; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), FATIGUE (FATIGUE) and CHILLS (CHILLS) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), FATIGUE (FATIGUE) and CHILLS (CHILLS). At the time of the report, HEADACHE (Headache), FATIGUE (FATIGUE) and CHILLS (CHILLS) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details were not reported.   Reporter did not allow further contact
possible 3rd dose to be administered; received in 2019 and Shingrix in 2022; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 66-year-old male patient who received Herpes zoster (Shingrix) (batch number DP2D3, expiry date 25th May 2023) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingles vaccine (1st dose received in 2019).   On 22nd February 2022, the patient received the 2nd dose of Shingrix. On an unknown date, the patient received the 3rd dose of Shingrix. On 22nd February 2022, unknown after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the patient experienced circumstance or information capable of leading to medication error. On an unknown date, the outcome of the drug dose administration interval too long and circumstance or information capable of leading to medication error were unknown.  Additional details were provided as follows: The age at vaccination was not applicable for 3rd dose. The patient received an unknown shingles vaccineas 1st dose and a dose of Shingrix was given the day before reporting, which led to lengthening of vaccination schedule. After the case was closed, the health care professional spoke with Medical information agent and stated that a possible 3rd dose to be administered in 2 months, which was circumstance or information capable of leading to medication error. It was not clear if the patient had prescription for 3rd dose or will erroneously receive it. The reporter consented to follow up.
This patient had a red, swollen arm noticed this AM. The site feels warm, about 2" below the injection site, area of about 2" long. Slightly itchy.
Information has been received from a RN concerning a healthy 6 yr old white female student who on 20Dec99 was vaccinated IM with a dose of varicella virus vaccine live (lot6320421360J). Concomitant vaccination given on the same day included: the fourth dose of Hib conj vaccine (crm197) (Hibtiter) (lot 520253A) given IM. On 22Mar05 the pt developed large macules with an inflammatory process around them; they were on her torso, neck and both arms. She was diagnosed with chicken pox. She was home from school for a week. The student recovered. No product quality complaint was involved. Additional information is not expected.
This spontaneous report received from a patient concerned a 37 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included alcohol use, and non-smoker, and other pre-existing medical conditions included the patient had no known drug allergies, no history of drug abuse or illicit drug use. The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, and expiry: 07-AUG-2021) dose was not reported, administered on 14-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 14-JUN-2021, the subject experienced flushing in face. On 15-JUN-2021, the subject experienced tiredness. On 15-JUN-2021, the subject experienced headache. On 16-JUN-2021, the subject experienced swelling occurring at both sides of eyes temple regions. On 16-JUN-2021, the subject experienced muscle tightening at corners of mastoids. Treatment medications (dates unspecified) included: ibuprofen. The action taken with COVID-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flushing in face on 14-JUN-2021, and tiredness on 16-JUN-2021, was recovering from headache, and had not recovered from swelling occurring at both sides of eyes temple regions, and muscle tightening at corners of mastoids. This report was non-serious.
Client was first given a Moderna booster dose (half dose).   Ensuing discussion about scheduling highlighted the error, that client had wanted a first dose.   Client was informed and offered a second half dose , she accepted and was given the remainder of the dose expected.
Patient had swelling of the left upper arm where the PNEUMOVAX had been administered. Presented to pharmacy instructed to see physician who diagnosed as similar to a cellulitis. Patient's arm was red with 1/8 inch thick hard red line separating healthy tissue from non healthy tissue. The left arm was very warm to the touch. Patient was given two prescriptions for cephalexin (10-day) and naproxen(month supply) which were started on 10/14. Patient had been unable to sleep for two nights and now on Monday with follow-up is able to sleep and function, although not feeling 100% better. The antibiotic treatment is causing stomach issues. Patient is taking yogurt to treat stomach upset and assist with GI flora.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On 23-SEP-2014 the patient was vaccinated with an expired dose of PNEUMOVAX 23  (lot # J006242, expiration date 03-AUG-2014), 0.5 ml, intramuscular. No adverse events were reported. Additional information has been requested.
Approx. 1 hour, post vax, the pt's heart rate decreased (per monitor). Apnea spells starting occurring. He was on 1/4 O2.
Left leg became red, warm and slightly edematous from leg/hip crease to knee and 1/2 way around thigh both medical and proximally. Given cephalexin to cover cellulitis and within 3 days the thigh was back to normal condition.
shingles outbreak; Incomplete course of vaccination; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In November 2018, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced shingles and incomplete course of vaccination. On an unknown date, the outcome of the shingles was not recovered/not resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix vaccine but did not have the specific date. The patient has an outbreak of shingles that started about a week or 10 days ago. She has not seen a physician to get a formal diagnosis yet. The patient would like to have her 2nd dose of Shingrix at the time of reporting but did not know if she could still have it, which led to incomplete course of vaccination. Did not collect reporter's phone number.
2 days following intermittent tachycardia at rest resolved in 24 hours.  1 week following L gh joint pain 4 days.  2 weeks later L elbow pain for 3 days edema res got to touch,  2 weeks later l gh joint pain edema hot red for 2 days 4 days later r gh joint pain 2 days,  3 days later r hand swollen hot and red lasted 3 days,  1 week later r gh joint pain for 2 days, 2 weeks later r gh joint pain lasting 1 week.
8 days after the shot, the shoulder where I received the injection developed a red rash that was raised and swollen. It was painful and warm to the touch. I called a doctor and they prescribed me antibiotics thinking it was an infection. The rash dissipated in another day or two and soreness went away but then returned 5 days later.
feels like a bruise at the injection site; This is a spontaneous report from a contactable consumer.   A 35-year-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Left Arm on 02Mar2021 14:15, at the age of 35-years-old, (Lot Number: EL3248) as DOSE 1, SINGLE for covid-19 immunisation.  Medical history included none. The patient is not pregnant at the time of vaccination. The patient did not have COIVD-19 prior vaccination. Concomitant medication includes multivitamin daily. The patient experienced feels like a bruise at the injection site on 03Mar2021 with outcome of recovering. The patient was not tested for COVID-19 post vaccination.  No treatment was received for the event.  No follow-up attempts are possible. No further information is expected.
Quarter size raised welt immediately after injection  applied instant ice pak while still at pharmacy  after 15 minutes welt reduced in size. Spoke to patient  3 hours later to follow up and he said no pain or welt in injection area
Delayed rash, on chest; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Delayed rash, on chest) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Mar-2021, the patient experienced RASH (Delayed rash, on chest). At the time of the report, RASH (Delayed rash, on chest) outcome was unknown. Not Provided          No Concomitant medication were reported. Treatment medication was not provided.
Wrong shot administered. My vaccination card states Moderna was the first vaccine administered, but with little care, was administered Pfizer today for shot #2. This shot has little testing known on it if the same vaccine is administered, let alone mixed shots which is not advised by the CDC. And of course no one will give me anything concrete to make me feel as though I won't receive an actual health event that hospitalized me due to this error.  The the administering health employee says they frequently administer mixed shots to those who had a bad reaction the the first shot. This is not recommended by the cdc and I highly doubt that is the case. I am requiring a phone call back to my cell in the next 24 hours with concrete information to assist me in my next steps. . Please call me this is not something to mess with people life like what happened today by mixing vaccines which are untested and which don't have approval.
Guillain-Barre' Syndrom  6/8/09 Hospital records and DC summary received DOS 4/03/09 to 4/17/09. Final Diagnosis: Guillain-Barre syndrome. Post vaccination transferred from another facility presenting with headache, photophobia, diplopia and generalized weakness. Complained of cervical pain, numbness and tingling in feet and hands. Areflexia. Trouble swallowing, facial diplegia, dysphonia. IVIg administered. Tachypneic. UTI.  6/9/09 ER records received DOS 4/3/09.  Includes records of 2 prior visits to other urgent care centers. Assessment: Polyneuropathy, ascending weakness. Post vaccination presents to ER with headache, progressive weakness, double vision, head sensitive to touch, photophobia, nausea. Pain, 'pins and needles' upper and lower extremities, unsteady gait, sensation decreased, DTRs decreased, patellar reflex absent. Symptoms worsening. UTI. Transfered to another hospital.  5/13/09 Rec PCP medical records of 3/13-4/3/09. Records reveal patient experienced nasal congestion, right eye tearing & tr urine protein on 3/13.  RTC 4/3 w/weakness of LEs x few days, sent to ED for LP.  6/23/09 ICD-9 codes received. 3570
No adverse event.  Moderna Booster for 18 years of age or older given.  Moderna bivalent booster should have been given.
This spontaneous report received from a patient concerned a 64 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: none. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018 expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021 for covid-19 prophylaxis. Age at time of vaccination 64 years old. No concomitant medications were reported. On 13-MAR-2021, the patient experienced a little lethargic. On 03-JAN-2022, the patient experienced suspected covid-19 infection. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from suspected covid-19 infection, and a little lethargic. This report was non-serious. This case, from the same reporter is linked to 20220733188. This report was associated with a product quality complaint: 90000242587.
PATIENT CAME IN THE PHARMACY 2 DAYS POST SHOT NUMBER 2 IN THE SERIES WITH A RED RASH AT THE SITE OF THE VACCINATION.  THE SITE WAS RED, WARM TO THE TOUCH, AND HARD.  NO DIFFICULTY BREATHING, OR SIGNS OF anaphylactic REACTION.  PATIENT HAS BEEN TAKING TYLENOL AND APPLYING ICE TO THE SITE SINCE DOSE ADMINISTRATION.  SHE HAD NO SIDE EFFECTS TO THE FIRST SHOT
3 days p/vax pt devel fever, h/a, & swollen lymph glands seen 9SEP96;h/a improved, no fever but was c/o new onset sore throat & swollen tonsillar nodes;faint, diffuse exanthem noted on trunk;
broke out in a shingles rash; This is a spontaneous report from a contactable physician. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date (after the first dose), the patient broke out in a shingles rash. The patient was concerned if she should receive the second dose. The physician (caller) was asking if there have been any reports of shingles after vaccination that have been documented. The outcome of the event was unknown. Event was reported as non-serious.  Information about batch/lot number has been requested.
Broke out in a rash on the left side of the chest and a bit on the left arm. The rash started the following day after vaccination and continued increasing for 2 days. It has now stabilized but is still there (March 23rd).
Vaccine was expired for 13  days. Given inadvertently due to confusion in extended dates. vaccine stored in refrigerator and not ultra-cold. Used ultra-cold extended date instead of 10 week expiration date.
Patient received a dose of Pfizer vaccine.  It was noted that the vaccine 5 day expiration date/time was 5/12/2021 @ 930 am.  Vaccine was administered to patient at 9:52 am on 5/12/2021.  No adverse reactions noted during observation period.  MD and management team aware.
Information has been received from a registered nurse concerning a 9 week old female who on 05-FEB-2007 was vaccinated with a 2 ml oral first dose of Rotateq. On 12-FEB-2007 the patient experienced signs and symptoms of possible intussusception and was hospitalized. X rays were performed that showed that there was no intussusception and the patient was released on 13-FEB-2007 and was considered to be recovered. There was no product quality complaint involved. Additional information has been requested.
Patient developed hives across body the morning after receiving vaccination. Patient will receive and take Benadryl as a precaution. Patient directed to call EMS or visit hospital if he develops shortness of breath or condition worsens.
The left side of my throat started swelling around 2:30 pm,  on Friday, ?June 4, although my breathing and swallowing were not impacted.  I put a piece of hard candy in my mouth, hoping this would clear up.  The area beneath my tongue on the left side began to be painful about 10 minutes later.  This was evident whenever I swallowed or moved my tongue, such as in swallowing and speaking.  (Note: these continued until 1:30 am;  I tried to stay awake until it all dissipated but I felt drained and exhausted.)  After 35 minutes I left the ?recovery? area, reported my symptoms and took a bottle of water.   In my car I used my inhalant, finished my water and waited another ten minutes.  The coolish water helped the swelling feel better.  Once home I hydrated a lot with water, and found the cool water eased symptoms only if temporarily.   As the night progressed the symptoms eased a little.  When I awoke  the next morning, Saturday, June 5, the swelling had gone down a lot and the under-tongue pain was much lighter.   My arm, though, was achy when I moved my arm around but I did not feel the need to take pain relief medication.  I continued to use and move my arm and the pain decreased.  By the end of the night there was little discomfort, but the injection site muscles started to harden.     Ar3 these all normal currencies?